Bioelectric medicines, also known as electroceuticals, are medical devices that are used to restore health in patients. Bioelectric medicines function through neurostimulation and modulation of the nervous systems through electrical impulses. Asia Pacific bioelectric medicine market will grow by 9.3% annually with a total addressable market cap of $60.93 billion over 2021-2030 owing to the growing geriatric population and rising acceptance of bioelectric medicines.
Highlighted with 68 tables and 42 figures, this 140-page report “Asia Pacific Bioelectric Medicine Market 2020-2030 by Product Type (Implantable, Non-invasive), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific bioelectric medicine market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate/forecast from 2020 till 2030 with 2019 as the base year.
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific bioelectric medicine market in every aspect of the classification from perspectives of Product Type, End User, and Country.
Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Implantable Bioelectric Medicine
o Cardiac Pacemaker
o Implantable Cardioverter Defibrillators (ICD)
o Spinal Cord Stimulators (split into Chronic Pain, Failed Back Syndrome (FBSS), Ischemia by application)
o Cochlear Implants
o Deep Brain Stimulators (split into Parkinson’s Disease, Tremor, Depression, Other Deep Brain Stimulation Applications by application)
o Vagus Nerve Stimulators
o Sacral Nerve Stimulators (split into Urinary Incontinence and Fecal Incontinence by application)
o Retinal Implants
o Other Implantable Bioelectric Medicines
• Non-invasive Bioelectric Medicine
o Transcutaneous Electrical Nerve Stimulators
o Transcranial Magnetic Stimulation (TMS)
o Pulsed Electromagnetic Field Therapy
o Other Non-invasive Bioelectric Medicines
Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Hospitals and Clinics
• Research Institutes
• Individual Users
Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of the regional market by country and split of key national markets by Product Type and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Asia Pacific bioelectric medicine market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Laboratories
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
Cochlear Limited
electroCore, Inc.
Inspire Medical Systems, Inc.
LivaNova PLC
Medtronic PLC
NeuroMetrix, Inc
Nevro Corp.
Nuvectra Corporation
OMRON CORPORATION
Pixium Vision
Second Sight Medical Products Inc
SetPoint Medical
Sonova Holding AG
St. Jude Medical, Inc.
Stimwave LLC
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 6
1.1 Industry Definition and Research Scope 6
1.1.1 Industry Definition 6
1.1.2 Research Scope 7
1.2 Research Methodology 10
1.2.1 Overview of Market Research Methodology 10
1.2.2 Market Assumption 11
1.2.3 Secondary Data 11
1.2.4 Primary Data 11
1.2.5 Data Filtration and Model Design 12
1.2.6 Market Size/Share Estimation 13
1.2.7 Research Limitations 14
1.3 Executive Summary 15
2 Market Overview and Dynamics 17
2.1 Market Size and Forecast 17
2.1.1 Impact of COVID-19 on World Economy 18
2.1.2 Impact of COVID-19 on the Market 20
2.2 Major Growth Drivers 22
2.3 Market Restraints and Challenges 28
2.4 Emerging Opportunities and Market Trends 31
2.5 Porter’s Fiver Forces Analysis 35
3 Segmentation of Asia Pacific Market by Product Type 39
3.1 Market Overview by Product Type 39
3.2 Implantable Bioelectric Medicine 41
3.2.1 Cardiac Pacemaker 43
3.2.2 Implantable Cardioverter Defibrillators (ICD) 44
3.2.3 Spinal Cord Stimulators 45
3.2.4 Cochlear Implants 46
3.2.5 Deep Brain Stimulators 47
3.2.6 Vagus Nerve Stimulators 48
3.2.7 Sacral Nerve Stimulators 49
3.2.8 Retinal Implants 50
3.2.9 Other Implantable Bioelectric Medicines 51
3.3 Non-invasive Bioelectric Medicine 52
3.3.1 Transcutaneous Electrical Nerve Stimulators 54
3.3.2 Transcranial Magnetic Stimulation (TMS) 55
3.3.3 Pulsed Electromagnetic Field Therapy 56
3.3.4 Other Non-invasive Bioelectric Medicines 57
4 Segmentation of Asia Pacific Market by End User 58
4.1 Market Overview by End User 58
4.2 Hospitals and Clinics 60
4.3 Research Institutes 61
4.4 Individual Users 62
5 Asia-Pacific Market 2020-2030 by Country 63
5.1 Overview of Asia-Pacific Market 63
5.2 Japan 66
5.3 China 69
5.4 Australia 72
5.5 India 74
5.6 South Korea 76
5.7 Rest of APAC Region 78
6 Competitive Landscape 80
6.1 Overview of Key Vendors 80
6.2 New Product Launch, Partnership, Investment, and M&A 86
6.3 Company Profiles 87
Abbott Laboratories 87
BIOTRONIK SE & Co. KG 90
Boston Scientific Corporation 94
Cochlear Limited 98
electroCore, Inc. 101
Inspire Medical Systems, Inc. 103
LivaNova PLC 105
Medtronic PLC 107
NeuroMetrix, Inc 111
Nevro Corp. 113
Nuvectra Corporation 115
OMRON CORPORATION 117
Pixium Vision 120
Second Sight Medical Products Inc 123
SetPoint Medical 126
Sonova Holding AG 128
St. Jude Medical, Inc. 130
Stimwave LLC 132
7 Investing in Asia Pacific Market: Risk Assessment and Management 134
7.1 Risk Evaluation of Asia Pacific Market 134
7.2 Critical Success Factors (CSFs) 137
Related Reports and Products 140
Table 1. Snapshot of Asia Pacific Bioelectric Medicine Market in Balanced Perspective, 2020-2030 16
Table 2. Growth Rate of World GDP, 2020-2022 19
Table 3. Projection of Asia Pacific Disease Incidences Treated by Bioelectric Medicine, 2019-2030, million 25
Table 4. World Health Spending by Region, $ bn, 2013-2020 27
Table 5. Selected Examples of Product Recalls 30
Table 6. Main Product Trends and Market Opportunities in Asia Pacific Bioelectric Medicine Market 31
Table 7. Asia Pacific Bioelectric Medicine Market by Product Type, 2019-2030, $ mn 39
Table 8. Asia Pacific Implantable Bioelectric Medicine Market by Product Type, 2019-2030, $ mn 42
Table 9. Asia Pacific Bioelectric Medicine Market: Spinal Cord Stimulators by Application, 2019-2030, $ mn 45
Table 10. Asia Pacific Bioelectric Medicine Market: Deep Brain Stimulators by Application, 2019-2030, $ mn 47
Table 11. Asia Pacific Bioelectric Medicine Market: Sacral Nerve Stimulators by Application, 2019-2030, $ mn 49
Table 12. Asia Pacific Non-invasive Bioelectric Medicine Market by Product Type, 2019-2030, $ mn 53
Table 13. Asia Pacific Bioelectric Medicine Market by End User, 2019-2030, $ mn 58
Table 14. APAC Bioelectric Medicine Market by Country, 2019-2030, $ mn 64
Table 15. Japan Bioelectric Medicine Market by Product Type, 2019-2030, $ mn 68
Table 16. Japan Bioelectric Medicine Market by End User, 2019-2030, $ mn 68
Table 17. China Bioelectric Medicine Market by Product Type, 2019-2030, $ mn 70
Table 18. China Bioelectric Medicine Market by End User, 2019-2030, $ mn 70
Table 19. Australia Bioelectric Medicine Market by Product Type, 2019-2030, $ mn 73
Table 20. Australia Bioelectric Medicine Market by End User, 2019-2030, $ mn 73
Table 21. India Bioelectric Medicine Market by Product Type, 2019-2030, $ mn 75
Table 22. India Bioelectric Medicine Market by End User, 2019-2030, $ mn 75
Table 23. South Korea Bioelectric Medicine Market by Product Type, 2019-2030, $ mn 77
Table 24. South Korea Bioelectric Medicine Market by End User, 2019-2030, $ mn 77
Table 25. Bioelectric Medicine Market in Rest of APAC by Country, 2019-2030, $ mn 79
Table 26. Spinal Cord Stimulation Device Market by Key Vendor, 2019, % 82
Table 27. Cochlear Implant Market by Key Vendor, 2019, % 82
Table 28. Pacemaker and ICD Market by Key Vendor, 2019, % 82
Table 29. FDA Approved Products of Key Vendors 83
Table 30. Abbott Laboratories: Company Snapshot 87
Table 31. Abbott Laboratories: Business Segmentation 88
Table 32. Abbott Laboratories: Product Portfolio 88
Table 33. Abbott Laboratories: Revenue, 2018-2020, $ mn 89
Table 34. BIOTRONIK SE & Co. KG: Company Snapshot 90
Table 35. Boston Scientific Corp.: Company Snapshot 94
Table 36. Boston Scientific Corp.: Business Segmentation 94
Table 37. Boston Scientific Corp.: Product Portfolio of Medical Devices 95
Table 38. Cochlear Limited: Company Snapshot 98
Table 39. Cochlear Limited: Operational Overview with Sales Revenue ($ mn) and Sales Volume (units), 2020-2021 98
Table 40. Cochlear Limited: Product Portfolio 99
Table 41. electroCore, Inc.: Company Snapshot 101
Table 42. Inspire Medical Systems, Inc..: Company Snapshot 103
Table 43. LivaNova PLC: Company Snapshot 105
Table 44. LivaNova PLC: Product Portfolio 106
Table 45. Medtronic Inc.: Company Snapshot 107
Table 46. Medtronic Inc.: Net Revenue by Segment, 2018-2020, $ bn 108
Table 47. Medtronic Inc.: Net Revenue by Region, 2017-2019, $ bn 108
Table 48. Medtronic Inc.: Product Portfolio of Medical Devices 108
Table 49. Medtronic Inc.: Product Portfolio of Bioelectric Medicine 109
Table 50. NeuroMetrix, Inc: Company Snapshot 111
Table 51. NeuroMetrix, Inc: Product Portfolio 112
Table 52. Nevro Corp.: Company Snapshot 113
Table 53. Nevro Corp.: Product Portfolio 114
Table 54. Nuvectra Corporation: Company Snapshot 115
Table 55. Omron Corporation: Company Snapshot 117
Table 56. Omron Corporation: Business Segmentation 118
Table 57. Pixium Vision: Company Snapshot 120
Table 58. Pixium Vision: Product Portfolio 121
Table 59. Second Sight Medical Products Inc: Company Snapshot 123
Table 60. Second Sight Medical Products Inc: Product Portfolio 124
Table 61. SetPoint Medical: Company Snapshot 126
Table 62. Sonova Holding AG: Company Snapshot 128
Table 63. Sonova Holding AG: Main Brands and Products 129
Table 64. St. Jude Medical, Inc.: Company Snapshot 130
Table 65. Stimwave LLC: Company Snapshot 132
Table 66. Stimwave LLC: Product Portfolio 133
Table 67. Risk Evaluation for Investing in Asia Pacific Market, 2020-2030 135
Table 68. Critical Success Factors and Key Takeaways 138
